Araicom was created to help biomedical and life sciences researchers find answers faster to deliver better cures and solutions that improve the quality of life. Our comprehensive platform solution will make “conceptual biology and computational literature discovery” a practical reality throughout the biomedical and life sciences industries. Accelerate researchers path to insight by going beyond "search" and revealing the hidden relationships that reside within published medical findings.

Expand researchers ability to productively explore and harvest the conceptual associations and relationships that reside among silos and communities of information.

Simplify the research process with an easy-to-use browser-based profiler that visually navigates standard terminology vocabularies and associations.

Improve speed in discovery and hypothesis by unifying disparate terminology and coding vocabularies through a virtual layer of references that integrate existing catalogue and thesaurus systems.

Enhance researcher productivity by identifying relevant concepts and harvesting the significant relationships that lie hidden in the information.

Ever since people began writing, we have been capturing and storing information. Our storage capacity has always exceeded our ability to find what we need, when we need it. Technology may have enhanced our retrieval ability, but it has not evolved to a point where it can help us quickly comprehend and apply information in meaningful ways – until now.

Araicom's computationally intelligent research system gives users the tools to rapidly map the conceptual relationships that lie hidden within literature. With its power of discovery, our system is the next step towards artificial intelligence. To see a graphical representation of how we are driving the evolution of information into insight, please click here.

Founded in 2005, Araicom Research, LLC is directed by CEO Anthony Prestigiacomo, and controls Mr. Prestigiacomo’s research projects and an active Intellectual Property portfolio including issued patents and current applications, licenses, publications and technology source code repositories as well patent sales and licensing agreements, grant proposals and collaborations plus new patents in development.

Mr. Prestigiacomo is currently working through Araicom Research to support commercialization of the Araicom IP portfolio with BioCAID, Inc. (www.biocaid.com) to develop, patent and market an advanced Literature-Based Discovery SaaS platform for Intelligent MEDLINE Discovery Integration (IMDI) and the Profiler family of applications supporting Internet consumer health searchers and advanced applications for academic, commercial and healthcare researchers with Domain Framework AI incorporating Deep Learning and Reasoning AI with Decision Support.

IMDI Profiler uses advanced peer-reviewed, patented, and validated algorithms and technologies to develop “Assistive” applications with intelligent hypothesis algorithms for exploratory, confirmatory and predictive AI tools and semantic conceptualization.

IMDI Profiler applications deliver controlled ontological knowledge structures based on professional vocabularies, thesauri, and publication analytics with integrated, easy to use visualization, navigation, and curation of researcher investigations beyond current Search portal capabilities.

Araicom Research and Mr. Prestigiacomo have worked since 2001 with National Institutes of Health (NIH) and National Cancer Institute (NCI), National Center for Biotechnology Information (NCBI), and National Library of Medicine programs for MEDLARS (MEDLINE), Unified Medical Language System (UMLS) and Medical Subject Heading (MeSH) as a licensed researcher and as member of the NCBI caBIG Partial Data Control Gold Standards Review Committee.

Araicom Research is listed in NIH ERA Commons as a Federally approved grant contractor.

Mr. Prestigiacomo’s patents and publications can be reviewed at the Researchgate profile below:

Linkedin Profile: https://www.linkedin.com/in/anthony-prestigiacomo-85196915/

Researchgate Profile: https://www.researchgate.net/profile/Anthony_Prestigiacomo